OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Radiation Pneumonitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,116 reports · 48 co-occurring drugs

As of the last recalculation, Radiation Pneumonitis appears in 2,116 FAERS reports alongside 48 co-occurring drug terms. The strongest observed disproportionality signal is DURVALUMAB (PRR 630.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Durvalumab807630.1656.3
Carboplatin31128.128.1
Nivolumab23126.326.3
Pemetrexed Disodium9124.524.6
Gefitinib2224.224.3
Pemetrexed5123.924.0
Paclitaxel (Aibumin-Bound)18223.723.8
Ado-Trastuzumab Emtansine2023.523.6
Cisplatin16322.222.2
Paclitaxel20021.821.9
Atezolizumab7419.419.4
Erlotinib Hydrochloride2217.517.5
Erlotinib1717.417.4
Ipilimumab7317.217.2
Osimertinib5216.316.4
Abemaciclib3216.016.0
Pembrolizumab15615.715.7
Etoposide8311.511.5
Moxifloxacin1611.211.3
Fam-Trastuzumab Deruxtecan-Nxki1110.810.8
Prednisolone Acetate1110.510.5
Cimetidine1010.310.3
Methadone Hydrochloride1110.010.1
Pertuzumab279.99.9
Magnesium Oxide409.69.6
Cetuximab309.59.5
Nystatin Ointment249.19.1
Nystatin Cream249.19.1
Moxifloxacin Hydrochloride188.88.8
Ifosfamide198.88.8
Nystatin248.78.7
Docetaxel Anhydrous588.78.7
Docetaxel588.78.7
Suvorexant118.48.4
Lapatinib138.38.3
Trastuzumab517.57.5
Anastrozole Tablets167.47.4
Pitavastatin Calcium76.76.8
Bleomycin Sulfate76.76.7
Granisetron Hydrochloride65.75.7
Fluorouracil Cream, 0.5%425.55.5
Crizotinib75.45.4
Fluorouracil425.45.4
Aprepitant105.35.4
Methadone214.94.9
Brentuximab Vedotin54.84.8
Bevacizumab504.04.0
Cabozantinib132.72.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.